Anastasia Papadopoulou

11PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersInnate immunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 04, 2026
Early Immunological Biomarkers for Personalized Treatment Selection in Severe COVID-19: Post Hoc Machine Learning Analysis of a Randomized Clinical Trial.

|Oct 28, 2023
Immune Profile Determines Response to Vaccination against COVID-19 in Kidney Transplant Recipients.

Stamatia Stai, Asimina Fylaktou, Efstratios Kasimatis

|Jul 17, 2023
SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial.

Anastasia Papadopoulou, George Karavalakis, Efthymia Papadopoulou

|Apr 13, 2023
Empowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming.

Maria Alvanou, Memnon Lysandrou, Panayota Christophi

|Dec 23, 2022
In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations.

Nikoletta Psatha, Kiriaki Paschoudi, Anastasia Papadopoulou

|Oct 03, 2022
The diverse genetic origins of a Classical period Greek army.

Laurie J Reitsema, Alissa Mittnik, Britney Kyle

Pageof 2

Frequent Collaborators

4 joint publications

Evangelia Yannaki

3 joint publications

Achilles Anagnostopoulos

2 joint publications

Grigorios Georgolopoulos

1 joint publications

Nikolaos Savvopoulos